Prevention of brain metastases in human epidermal growth factor receptor 2-positive breast cancer.
Fiche publication
Date publication
novembre 2020
Journal
Current opinion in oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr EBERST Lauriane
Tous les auteurs :
Eberst L, Bailleux C, Bachelot T
Lien Pubmed
Résumé
For patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, treatments that could prevent or delay occurrence of brain metastases would improve outcome.
Mots clés
Brain Neoplasms, enzymology, Breast Neoplasms, drug therapy, Clinical Trials, Phase III as Topic, Cranial Irradiation, Female, Humans, Protein Kinase Inhibitors, pharmacology, Randomized Controlled Trials as Topic, Receptor, ErbB-2, antagonists & inhibitors
Référence
Curr Opin Oncol. 2020 11;32(6):555-560